Jasper Therapeutics, Inc., (JSPR): Price and Financial Metrics
JSPR Price/Volume Stats
| Current price | $20.98 | 52-week high | $31.01 |
| Prev. close | $20.69 | 52-week low | $4.00 |
| Day low | $19.79 | Volume | 216,600 |
| Day high | $21.00 | Avg. volume | 175,256 |
| 50-day MA | $20.28 | Dividend yield | N/A |
| 200-day MA | $21.77 | Market Cap | 314.72M |
JSPR Stock Price Chart Interactive Chart >
Jasper Therapeutics, Inc., (JSPR) Company Bio
Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies. The company develops JSP191, a humanized monoclonal antibody for clearing hematopoietic stem cells from bone marrow in patients undergoing a hematopoietic cell transplantation. It also develops Jasper eHSC Platform to overcome key limitations of allogeneic and autologous gene-edited stem cell grafts. The company is based in Redwood City, California.
JSPR Price Returns
| 1-mo | 4.48% |
| 3-mo | 8.76% |
| 6-mo | -12.29% |
| 1-year | 236.97% |
| 3-year | -72.54% |
| 5-year | N/A |
| YTD | 165.91% |
| 2023 | 63.39% |
| 2022 | -93.85% |
| 2021 | -21.58% |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...